Latest news with #DrReddy
Reuters
4 days ago
- Business
- Reuters
Indian drugmaker Cipla beats first-quarter profit view on higher domestic demand
July 25 (Reuters) - Cipla ( opens new tab, India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs. The company's consolidated net profit rose 10% to 12.98 billion rupees ($150 million) in the April-June quarter, beating analysts' average estimate of 12.11 billion rupees, per data compiled by LSEG. Total revenue increased 4% to 69.57 billion rupees, slightly below expectations of 70.64 billion rupees. Cipla's shares jumped 3.4% after the results and were set for their best day in nearly three months. The stock was the top gainer on the blue-chip Nifty 50 index (.NSEI), opens new tab. Revenue from India, Cipla's biggest market by sales, climbed 6% to 30.70 billion rupees, while North America revenue fell 7% to 19.33 billion rupees. The two regions account for three-fourths of the company's total sales. Cipla said growth in India was led by demand for drugs in therapy areas such as respiratory, urology and anti-infectives. However, delayed approvals for new drug applications and pricing pressure have weighed on the drugmaker's growth in the U.S. Drug prices in the U.S. are expected to drop as shortages ease and competition from new drugmakers intensifies, Macquarie analysts said in a pre-earnings note. Earlier this week, rival Dr Reddy's ( opens new tab missed quarterly profit estimates and flagged increased price erosion in certain key products, including lenalidomide in North America. ($1 = 86.5750 Indian rupees)
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
Q1 miss for Dr Reddy's, but analysts remain hopeful for future prospects
Despite missing Q1 expectations, Dr Reddy's continues to see growth in key markets like Europe and India, while managing costs to offset challenges in the US Devangshu Datta Mumbai Listen to This Article In the April-June quarter (Q1) of FY26, Dr Reddy's (DRL) US sales fell 4 per cent quarter-on-quarter (QoQ) to $400 million due to erosion in gRevlimid earnings caused by pricing pressure. On a positive note, DRL posted double-digit growth in most ex-US markets, but overall revenue disappointed. The absence of meaningful abbreviated new drug application (ANDA) approvals for DRL, as well as impending tariffs (since it has no US-based formulations facility), remain concerns. DRL's Q1 FY26 revenue grew 11 per cent year-on-year (YoY) to Rs 8,570 crore, and Europe sales jumped 1.4x YoY to Rs 1,270 crore (15 per cent
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
How to trade Dr Reddys, Tata Consumer, Bajaj Housing post Q1 results?
Technical charts hint at a likely positive bias for Dr Reddy's stock, while a negative outlook for Tata Consumer. Bajaj Housing Finance is likely to remain range-bound. Rex Cano Mumbai Listen to This Article Shares of Dr Reddy's Labs, Tata Consumer Products and Bajaj Housing were trading on a mixed note post Q1 results on Thursday. and Tata Consumer Products rallied 3 per cent and 4 per cent, respectively, while Bajaj Housing Finance stock slipped 1 per cent. So far in the calendar year 2025, Tata Consumer Products stock has zoomed over 18 per cent; whereas, Dr Reddy's and Bajaj Housing Finance shares prices have declined around 7.4 per cent and 5 per cent, respectively. In comparison, the NSE Nifty 50 index and the BSE Sensex have gained 6.4 per cent and
Mint
6 days ago
- Business
- Mint
Stocks to watch: Infosys, Bajaj Finance, Nestle India, BEML, IndusInd Bank among shares in focus today
Shares of Bajaj Finance, Adani Energy, Nestle India, SBI Life will remain in focus as companies will declare Q1 earnings today. Infosys, India's second-largest IT services exporter, posted a 9% year-on-year (YoY) increase in its consolidated net profit, reaching ₹ 6,921 crore for the quarter ending in June. Bajaj Finance subsidiary announced its first-quarter results, reporting a 33.4% increase in Net Interest Income to ₹ 887 crore, while net profit grew by 21% to ₹ 583 crore. Tata Consumer posted a 15% year-on-year increase in its consolidated net profit for Q1FY26, rising to ₹ 334 crore from ₹ 290 crore in the same quarter last year. Dr Reddy's reported a revenue of ₹ 8,542 crore, up from ₹ 7,672.7 crore in the previous year, though it fell slightly short of projections. The automobile major reported a 52.3% year-on-year increase in net profit, reaching ₹ 176.3 crore, while its revenue from operations grew by 21.9% to ₹ 2,297 crore for the June quarter. BEML has secured an order valued at ₹ 294 crore from the Ministry of Defence for the supply of 6x6 High Mobility Vehicles (HMVs). Welspun Corp has sold an additional 9.9% equity stake in Nauyaan Shipyard to Nauyaan Tradings, a wholly-owned subsidiary of Reliance Strategic Business Ventures, for ₹ 54.70 crore. The board of the private lender has given its approval to raise up to ₹ 30,000 crore through a mix of debt securities and equity instruments such as ADRs, GDRs, and QIPs, subject to obtaining the required approvals from shareholders and regulators. Inox Wind announced that its board has approved the specific terms for its proposed rights issue of equity shares worth up to ₹ 1,249 crore, after receiving in-principle approvals from both the BSE and NSE. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Economic Times
6 days ago
- Business
- Economic Times
Stocks in news: Infosys, Bajaj Finance, Nestle, Dr Reddy's, Inox Wind
Markets traded with a positive bias and gained over half a percent, offering some relief after the recent decline. In today's trade, shares of Infosys, Bajaj Finance, Nestle, IndusInd Bank, Inox Wind among others will be in focus due to various news developments and first quarter results. ADVERTISEMENT Bajaj Finance, Nestle, SBI Life, Adani Energy, Canara Bank, Motilal, IEX Shares of Bajaj Finance, Nestle, SBI Life, Adani Energy, Canara Bank, Motilal and IEX will be in focus as the company will announce its first quarter results. Tata Consumer Tata Consumer reported a 15% growth in its Q1FY26 consolidated net profit at Rs 334 crore versus Rs 290 crore in the year ago period. Dr Reddy's Pharma major Dr Reddy's reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418 crore for the first quarter ended June. Bajaj Housing Bajaj Housing Finance reported a 21% year-on-year jump in its net profit for the June quarter at Rs 583 crore. ADVERTISEMENT InfosysIndia's second largest IT services exporter Infosys reported 9% year-on-year (YoY) growth in its consolidated net profit at Rs 6,921 crore for the first quarter ended June. BEML BEML received order worth Rs 294 crore from the Ministry of Defence for the supply of HMV 6X6 ADVERTISEMENT Inox Wind Inox Wind said its board has approved the detailed terms of its proposed rights issue of equity shares aggregating up to Rs 1,249 crore, following in-principle approvals from BSE and NSE. IndusInd Bank IndusInd Bank will raise up to Rs 3000 crore ($3.47 billion). The Bank will issue debt worth Rs 2000 crore on a private placement basis and also increase capital by Rs 1000 crore through an additional issue or placement of securities. (You can now subscribe to our ETMarkets WhatsApp channel)
